Skip to main content
. 2017 May 23;13(3):319–330. doi: 10.1177/1559827617709757

Table 2.

Changes in Biometrics at Baseline and Immediate Postintervention (16 or 14 Weeks) for Both Cohorts (n = 39a).

Outcome Baseline Mean (SD) Postintervention Mean (SD) Mean Change % Change P Valueb
Weight (kg) 92.7 (25.7) 89.9 (24.6) −2.8 (4.0) −1.2% <0.05
BMI (kg/m2) 33.3 (8.4) 32.3 (8.1) −1.0 (1.5) −2.7% <0.05
Waist circumference (in.) 41.3 (8.0) 39.5 (7.9) −2.2 (2.8) −4.6% <0.05
SBP (mm Hg) 134.3 (20.0) 126.5 (17.5) −7.7 (15.5) −5.6% <0.05
DBP (mm Hg) 82.0 (10.2) 75.7 (11.9) −6.3 (9.1) −7.9% <0.05
Total cholesterol (mg/dL) 187.1 (41.7) 179.5 (41.9) −7.5 (23.1) −4.4% <0.05
Triglycerides (mg/dL) 124.5 (93.8) 112.3 (53.5) −12.2 (70.1) −9.8% 0.28
HDL (mg/dL) 52.4 (17.5) 50.5 (14.3) −1.9 (4.9) −3.6% 0.10
LDL (mg/dL)c 105.0 (34.5) 102.4 (33.6) −2.6 (14.7) −2.5% 0.44
Fasting glucose (mg/dL) 110.0 (53.3) 112.3 (53.7) 2.4 (13.5) +2.1% 0.28

Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, HDL, low-density lipoprotein.

a

N = 39 instead of 40 because measurements were not available for one participant due to a logistical lab error.

b

The baseline to postintervention difference for continuous variables were tested using 1-sample paired Student’s t tests. P < .05 indicates statistically significant differences.

c

LDL measures were only taken in Cohort 2, N = 20.